CN102093387B - 4,5,6,7-四氢异噁唑并[5,4-c]吡啶-3-醇一水合物的晶型化合物 - Google Patents
4,5,6,7-四氢异噁唑并[5,4-c]吡啶-3-醇一水合物的晶型化合物 Download PDFInfo
- Publication number
- CN102093387B CN102093387B CN2009102290671A CN200910229067A CN102093387B CN 102093387 B CN102093387 B CN 102093387B CN 2009102290671 A CN2009102290671 A CN 2009102290671A CN 200910229067 A CN200910229067 A CN 200910229067A CN 102093387 B CN102093387 B CN 102093387B
- Authority
- CN
- China
- Prior art keywords
- crystal formation
- pyridine
- formation compound
- alcohol
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
Description
溶解度 | |
实施例1制备的晶型化合物 | 1.4g |
CN1914212A中公开方法制备的晶型化合物 | 0.8g |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102290671A CN102093387B (zh) | 2009-12-10 | 2009-12-10 | 4,5,6,7-四氢异噁唑并[5,4-c]吡啶-3-醇一水合物的晶型化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102290671A CN102093387B (zh) | 2009-12-10 | 2009-12-10 | 4,5,6,7-四氢异噁唑并[5,4-c]吡啶-3-醇一水合物的晶型化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102093387A CN102093387A (zh) | 2011-06-15 |
CN102093387B true CN102093387B (zh) | 2012-07-25 |
Family
ID=44126673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102290671A Expired - Fee Related CN102093387B (zh) | 2009-12-10 | 2009-12-10 | 4,5,6,7-四氢异噁唑并[5,4-c]吡啶-3-醇一水合物的晶型化合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102093387B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105801510A (zh) * | 2016-04-08 | 2016-07-27 | 李勇 | 一种治疗抑郁症的药物组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006083682A2 (en) * | 2005-01-28 | 2006-08-10 | H.Lundbeck A/S | Polymorphic forms of a gabaa agonist |
WO2006102093A1 (en) * | 2005-03-18 | 2006-09-28 | Transform Pharmaceuticals, Inc. | Gaboxadol forms, compositions thereof, and related methods |
CN1914212A (zh) * | 2004-01-30 | 2007-02-14 | 默沙东有限公司 | Gabaa激动剂的多晶型 |
-
2009
- 2009-12-10 CN CN2009102290671A patent/CN102093387B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1914212A (zh) * | 2004-01-30 | 2007-02-14 | 默沙东有限公司 | Gabaa激动剂的多晶型 |
WO2006083682A2 (en) * | 2005-01-28 | 2006-08-10 | H.Lundbeck A/S | Polymorphic forms of a gabaa agonist |
WO2006102093A1 (en) * | 2005-03-18 | 2006-09-28 | Transform Pharmaceuticals, Inc. | Gaboxadol forms, compositions thereof, and related methods |
Non-Patent Citations (1)
Title |
---|
荣连招等.新型安眠药加波沙朵的合成.《中国药物化学杂志》.2007,第17卷(第3期),166-169. * |
Also Published As
Publication number | Publication date |
---|---|
CN102093387A (zh) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3810079B2 (ja) | 微粉化ネビボロールを含有する組成物 | |
KR102611445B1 (ko) | N-{4-[(6,7-디메톡시퀴놀린-4-일)옥시]페닐}-n′-(4-플루오로페닐) 시클로프로판-1,1-디카르복스아미드의 염의 결정성 고체 형태, 이들을 만들기 위한 제법, 그리고 이들의 이용 방법 | |
CN102351842A (zh) | 甲磺酸伊马替尼的f、g、h、i 和k晶形 | |
JP2023082086A (ja) | キナーゼ阻害剤化合物の結晶多形、それを含む医薬組成物及びその製造方法と応用 | |
CN101407511B (zh) | 一种结晶型的咪唑-5-羧酸衍生物 | |
EP1844017A1 (en) | An amorphous and three crystalline forms of rimonabant hydrochloride | |
CN110483486A (zh) | 一种奥西替尼酮咯酸盐晶型及其制备方法 | |
US20080145425A1 (en) | Pharmaceutical composition of zolpidem | |
CN101597272B (zh) | 艾拉莫德的钾盐化合物,其制备方法和药物应用 | |
CN105801568B (zh) | 阿法替尼一马来酸盐晶型及其制备方法和药物组合物 | |
CN107522625A (zh) | 一种地佐辛a晶型及其制备方法 | |
CN102093387B (zh) | 4,5,6,7-四氢异噁唑并[5,4-c]吡啶-3-醇一水合物的晶型化合物 | |
WO2012055163A1 (zh) | 来曲唑i型结晶及其制备方法 | |
CN102093309B (zh) | 非布司他的晶型及其制备方法 | |
CN101993417A (zh) | 磷酸二甲啡烷的稳定新晶型 | |
WO2002067935A1 (en) | A stable pharmaceutical formulation comprising torsemide modification ii | |
PL194752B1 (pl) | Krystaliczna postać VI 5,6-dichloro-2-(izopropyloamino)-1-(ß-L-rybofuranozylo)-1H-benzimidazolu, sposób jej wytwarzania, kompozycja farmaceutyczna zawierająca krystaliczną postać i zastosowanie krystalicznej postaci | |
CN100432090C (zh) | I晶型3,4',5-三羟基茋-3-β-D-葡萄糖苷 | |
DE602004010837T2 (de) | Pharmazeutische zusammensetzung auf basis eines idazoxan-salzes oder eines seiner polymorphen | |
CN109721557A (zh) | 来曲唑晶ii型固体物质及制备方法和其药物组合物与用途 | |
CN110354093A (zh) | 一种枸橼酸莫沙必利药物组合物 | |
KR20210028680A (ko) | 융합된 트리사이클릭 감마-아미노산 유도체의 조성물 및 이의 제조 방법 | |
US20230089334A1 (en) | Hydrate of dimethylaminomicheliolide fumarate and preparation method therefor and use thereof | |
CN111662354B (zh) | 米非司酮晶n型固体物质及制备方法和其药物组合物与用途 | |
CN102503935A (zh) | 一种阿折地平新晶型及其制备方法和药用组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN TAIPU PHARMACEUTICAL INTELLECTUAL PROPERTY Free format text: FORMER OWNER: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH Effective date: 20120112 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120112 Address after: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Applicant after: TIANJIN TIPR PHARMACEUTICAL INTELLECTUAL PROPERTY TRANSFER CENTER Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Applicant before: Tianjin Institute of Pharmaceutical Research |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH Free format text: FORMER OWNER: TIANJIN TAIPU PHARMACEUTICAL INTELLECTUAL PROPERTY TRANSFER RESERVE CENTER CO., LTD. Effective date: 20140605 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140605 Address after: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee after: Tianjin Institute of Pharmaceutical Research Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: TIANJIN TIPR PHARMACEUTICAL INTELLECTUAL PROPERTY TRANSFER CENTER |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 Termination date: 20211210 |
|
CF01 | Termination of patent right due to non-payment of annual fee |